Clinical trial
Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma…
NCT00334750 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed
Key facts
| NCT number | NCT00334750 |
|---|---|
| Title | Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada |
| Official title | Distribution of Risk Factors Amongst Ocular Hypertension and Open-Angle Glaucoma Patients in Canada |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Glaucoma, Open-Angle, Ocular Hypertension |
| Intervention type | Other |
| Interventions | There is no intervention in this study. |
| Enrollment | 410 |
| Start date | Nov 1, 2007 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | Jun 8, 2006 |
| Last update posted | Feb 2, 2021 |
| Countries | Canada |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: